2023 Cell Therapy Landscape Review

In 2023, the market for cell therapy witnessed a definite shift from focusing on cancer treatment to an increased growth rate of 10% in non-oncology deals. This change has created challenges in keeping up with emerging modalities in this evolving field. Our Cell Therapy team has compiled a comprehensive review of the 2023 landscape, analyzing the challenges developers faced and are likely to face in the upcoming years.

You can access your copy of the report for an in-depth examination of the current scenario, a recap of regulatory announcements in 2023, and insights into the future of the cell therapy space.

Download Here

Discover the 2023 Cell Therapy Landscape Review

A comprehensive analysis of the drug, trial, and commercial landscape, including updates from 2023, relevant regulatory announcements, and the future of the cell therapy landscape.

Download Here

About the 2023 Landscape Review

The Cell Therapy field is evolving fast. CAR T cells and CD19 are the most commonly developed therapeutic classes. Armored cell therapies with KI, KO, and KD genes are gaining interest. In 2023, cell therapy expanded, particularly in autoimmune diseases. Exagamglogene autotemcel, the first CRISPR-edited cell therapy received landmark approval.

Developers are moving away from developing T Cells and into NK cells. Over 60% of NK therapies are allogeneic versus only 21% of T cell therapies. It’s important to follow trends in patient enrolment for early phase trials for non-oncology indications, with a 10% growth rate in non-oncology deals compared to a 10% decrease in cancer indications. Get all this information and more in our 2023 Cell Therapy Landscape report. Download now.

Find out more

Beacon is the essential decision-support tool for developers of complex therapeutics. Our market-defining, proprietary ontologies combined with the most accurate and comprehensive life sciences data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape.

Each dataset features proprietary, hyper-relevant search and filtering tailored to specific modalities, in-depth data, plus additional market insight curated by our subject matter experts. Beacon is here to support you in making these decisions with confidence through our encompassing database solution.